Legislation Tracker

July 21, 2025

Bill reintroduced in the House for the 119th Congress (H.R.4581).

July 21, 2025

Introduced

Bill reintroduced in the House for the 119th Congress (H.R. 4581). Also reintroduced in the Senate for the 119th Congress (S.2372). Rep. Doris Matsui's (D-CA) office published this press release. American Hospital Association (AHA) published this press release.

March 11, 2024

The bill is introduced in the House. Press release on the bill.

About

Description for 118th Congress:

This legislation would:

Clarify that manufacturers are required to offer 340B discount prices to covered entities regardless of the manner or location in which a drug is dispensed, including if a covered entity uses a contract pharmacy to dispense 340B drugs to the entity’s patients.
Ensure that manufacturers cannot place conditions on the ability of a covered entity to purchase and use 340B drugs, regardless of the manner or location in which the drug is dispensed, including through contract pharmacies.
Impose civil monetary penalties on manufacturers that violate these statutory requirements and prohibitions.

See Full Bill

Quick Facts

Introduced: July 21, 2025
Sponsor: (House Lead) Rep. Doris Matsui (D-CA), (Senator Lead) Sen. Peter Welch (D-VT)
Committee: House: Energy & Commerce; Senate: Health, Education, Labor, and Pensions
Number of cosponsors: House: 15, Senate: 2 (as of November 13, 2025)

The 340B PATIENTS Act of 2025

Legislation Tracker